20/20 Biolabs annual operating margin
2023
2024
2025
20/20 Biolabs Operating Margin Growth & History (AIDX)
20/20 Biolabs's operating margin was −162.87% for fiscal 2025.
View full 20/20 Biolabs company overview20/20 Biolabs annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −162.87% | +161.12 pp |
| 2024 | 2024-12-31 | −323.99% | +122.65 pp |
| 2023 | 2023-12-31 | −446.64% | — |
20/20 Biolabs quarterly operating margin
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −170.31% | −12.26 pp |
| Q1 2026 | 2026-03-31 | −408.45% | −269.02 pp |
| Q4 2025 | 2025-12-31 | −169.59% | +62.47 pp |
| Q3 2025 | 2025-09-30 | −191.44% | — |
| Q2 2025 | 2025-06-30 | −158.05% | — |
| Q1 2025 | 2025-03-31 | −139.43% | — |
| Q4 2024 | 2024-12-31 | −232.05% | — |
20/20 Biolabs operating margin trends
Between the periods ended 2023-12-31 and 2025-12-31, 20/20 Biolabs's operating margin increased from −446.64% to −162.87%, a change of +283.77 percentage points. The latest reported quarter, Q2 2026, shows −170.31%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 20/20 Biolabs source filings ↗